ACCURATE Study for Subjects With Dry Eyes

Phase 4 Completed 30 enrolled The Eye Centers of Racine and Kenosha

RandomizedParallel-groupOpen-labelTreatment

Summary

To determine treatment and imaging outcomes in bilateral ocular surface disease management with an intracanalicular dexamethasone (0.4 mg) insert compared to standard topical over-the-counter artificial tears lubrication management

Timeline

Start: 2019-12-16
Primary completion: 2021-12-30
Completion: 2021-12-30

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dexamethasone	Small molecule	0.4 mg	Other

ACCURATE Study for Subjects With Dry Eyes

Summary

Timeline

Drugs

Indications